Modernizing Oracle Exadata to Azure Synapse for a leading Biopharmaceutical Firm

Our client, who is a leading biopharmaceutical company in the US and provides clinical research, medical communications, consulting and advanced technology products and services, was facing issues with their current EDW on Oracle Exadata. It was incapable of handling large enterprise data volumes generated from clinical trials and research. Moreover, it was becoming very expensive to maintain and manage their legacy DW appliance. Their Total Cost of Ownership (TCO) was skyrocketing.

We proposed using Microsoft Azure data service components to achieve agility and cost effectiveness. The newly architected solution involved extracting data from various data sources into Azure Data Lake. Azure Synapse Analytics was selected to replace Oracle Exadata as the new EDW, where data would be used for reporting, analytics, and ad hoc querying.

The entire migration was automated using Amaze® for Data & AI platform.

Key Benefits

1. Leveraging Azure Synapse Analytics, the TCO was reduced by 45%.
2. The new cloud ecosystem brought better scalability, security, and querying ability.
3. Amaze^® for Data & AI automated the entire migration process, enabling the entire engagement cycle to be completed in 11 months.